Michael B. Bracken
386 works · 38,190 citations · h-index 86
Top works
- Complement Factor H Polymorphism in Age-Related Macular Degeneration
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury
- Clinically useful measures of effect in binary analyses of randomized trials
- International Standards for Neurological and Functional Classification of Spinal Cord Injury
- Effective care of the newborn infant
- Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study
- How to increase value and reduce waste when research priorities are set
- Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data
- Administration of Methylprednisolone for 24 or 48 Hours or Tirilazad Mesylate for 48 Hours in the Treatment of Acute Spinal Cord Injury
- Clinical Trials in Head Injury
- Where is the evidence that animal research benefits humans?
- Efficacy of Methylprednisolone in Acute Spinal Cord Injury
- Renal Impairment and Outcomes in Heart Failure
- INCIDENCE OF ACUTE TRAUMATIC HOSPITALIZED SPINAL CORD INJURY IN THE UNITED STATES, 1970–19771
- When can odds ratios mislead?
- Meta-analysis of the relationship between asymptomatic bacteriuria and preterm delivery/low birth weight.
- Methylprednisolone and neurological function 1 year after spinal cord injury
- A Randomized, Controlled Trial of Methylprednisolone or Naloxone in the Treatment of Acute Spinal-Cord Injury
- Maternal age: an independent risk factor for cesarean delivery.
- ASSOCIATION OF LOW BIRTH WEIGHT WITH PASSIVE SMOKE EXPOSURE IN PREGNANCY1